Omnitura Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2001-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.omnitura.com
Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance
- First Posted Date
- 2018-04-12
- Last Posted Date
- 2021-10-18
- Lead Sponsor
- Omnitura Therapeutics, Inc.
- Registration Number
- NCT03495479
A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas
Phase 1
Completed
- Conditions
- Neoplasms
- Interventions
- Drug: Aneustat (OMN54)
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2015-04-08
- Lead Sponsor
- Omnitura Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT01555242
- Locations
- 🇨🇦
BC Cancer Agency-Vancouver Centre, Vancouver, British Columbia, Canada
© Copyright 2025. All Rights Reserved by MedPath